Studies have shown that 510% weight loss can improve insulin resistance, dyslipidemia, glucose tolerance, menstrual function, ovulation, and pregnancy
Chemotherapy Recovery Enhancement Preliminary Research Research demonstrates FOXO4-DRI's potential to accelerate recovery from chemotherapy-induced damage by eliminating senescent cells that accumulate following cytotoxic cancer treatment and contribute to long-term side effects
Dosing is personalized, typically starting at 5 mg and gradually increasing to a maximum of 25 mg/day under clinical supervision
Many unapproved peptides demonstrate favorable tissue repair and metabolic outcomes in animal models, but rigorous human safety data are scarce, and there is potential for serious harm to patients
Slower Correction Restoring levels may take longer compared to injections
Manufactured without milk, eggs, fish, crustacean shellfish, peanuts, wheat and gluten